theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Pulmonology

Transplant Infectious Disease   

Questions discussed in this category


What factors influence your decision to initiate antifungal treatment in asymptomatic lung transplant recipients colonized with Aspergillus?
1 Answer available

Would you consider antifungal prophylaxis for immunocompromised patients with COVID-19 requiring mechanical ventilation, considering the high risk of invasive pulmonary aspergillosis in patients with severe COVID-19?
Feys et al., PMID 37691392 
1 Answer available

What is your preferred agent for fungal prophylaxis in a patient post lung transplant with abnormal LFTs?
Do you consider isavuconazole to be less hepatotoxic than other azoles?
2 Answers available

Do you treat non-albicans strains of Candida on sputum culture or BAL in patients who are immunosuppressed?
2 Answers available
24310209032281221659

Related Topics in Pulmonology

  • Lung Cancer
  • Breast Cancer
  • Head and Neck Cancers
  • Hematologic Malignancies
  • Radiation Oncology
  • Gynecologic Oncology
  • Palliation
  • Neuro-Oncology
  • Gastrointestinal Cancers
  • Melanoma/Skin Cancer

Copyright © 2025 theMednet
All Rights Reserved.